Session Details
Poster 17
Sat. Sep 27, 2025 10:00 AM - 11:00 AM JST
Sat. Sep 27, 2025 1:00 AM - 2:00 AM UTC
Sat. Sep 27, 2025 1:00 AM - 2:00 AM UTC
Poster Session Hall (Foyer 1)
[P-17-01]Conditions Associated with Deaths in Individuals with Schizophrenia in Psychiatric Units
*Michitaka Funayama (Ashikaga Red Cross Hospital(Japan))
[P-17-02]Exploring Changes in Recognition and Stigmatization Toward Individuals with Schizophrenia in Singapore from 2014 to 2022
*Ke Cao1, Edimansyah Abdin2, Mythily Subramaniam2 (1.Duke-NUS Medical School(Singapore), 2.Institute of Mental Health(Singapore))
[P-17-03]A study on the treatment of psychosis induced by invocation, Kitousei-Seishinbyo
*Fumiya Miyano (Department of Psychiatry, Hokkaido University Graduate School of Medicine(Japan))
[P-17-04]PHARMACOTHERAPY OF CATATONIA WITH MODERN ANTIPSYCHOTIC AGENTS: ETHNO-CULTURAL FEATURES OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA AND COMORBID CHEMICAL ADDICTIONS IN THE NORTHWESTERN AND SIBERIAN FEDERAL DISTRICTS OF RUSSIA.
Georgy Yu. Selivanov1,2,3, Nikolay A. Bokhan1, *Svetlana V. Vladimirova1 (1.Mental Health Research Institute, Tomsk(Russia), 2.Saint Petersburg University of State Fire Service of Emercom of Russia(Russia), 3.Psychiatric Hospital of St. Nicholas, St. Petersburg(Russia))
[P-17-05]Evaluation of ZNF804A (rs1344706) Polymorphism in a Familial Case of Schizophrenia
*Halil ibrahim tas (Ordu university(Turkey))
[P-17-06]Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer- a prospective follow up study
*Shu-I Wu1, Ching-Hung Chen2 (1.Mackay Memorial Hospital(Taiwan), 2.Chia-Yi Chang Gung Memorial Hospital(Taiwan))